⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MRK News
Merck & Co., Inc.
U.S. FDA Accepts sBLA for ENFLONSIA™ (clesrovimab-cfor) to Update its Respiratory Syncytial Virus (RSV) Lower Respiratory Tract Disease Indication to Include Children Under Two Years at Increased Risk for Severe RSV for Their Second Season
businesswire.com
MRK
zerohash Powers Stablecoin Payout and Prefunding Capabilities for Visa Direct
globenewswire.com
V
MS
MRK
WRLD
Global Point-of-Care Molecular Diagnostics Market is Expected to Expand at a Healthy Growth Rate of ~10% by 2034 | DelveInsight
globenewswire.com
BDX
DHR
ABT
QDEL
FLUX
TMO
DGX
ILMN
EXAS
BIO
BIIB
GILD
AMGN
MRK
PACB
CRSP
EDIT
BEAM
MilliporeSigma Wins 2026 Business Intelligence Group Sustainability Product of The Year Award
accessnewswire.com
MRK
PM360 Announces 2026 Lifetime Achievement Award Honoree, CMO of the Year, and Brand Champions
prnewswire.com
LLY
JNJ
BMY
MRK
REGN
KURA
BMRN
TAK
VRTX
GSK
AZN
AMGN
ABBV
The Hashgraph Group Launches Hashgraph Partner Alliance for Enterprise Web3 and AI Deployments
prnewswire.com
MRK
TailorMed and RxSense Partner to Surface Manufacturer Copay Assistance Within Digital Pharmacy Marketplaces
accessnewswire.com
BMY
SNY
MRK
LLY
Form 8-K
sec.gov
MRK
Merck & Co., Inc., Rahway, N.J., USA Announces Second-Quarter 2026 Financial Results; Highlights Key Regulatory and Clinical Milestones Across Broad, Diverse Pipeline
businesswire.com
MRK
Evexta Bio gibt eine Kooperations- und Liefervereinbarung mit Roche zur klinischen Prüfung von Rupitasertib in Kombination mit einem selektiven Östrogenrezeptor-Degrader bei fortgeschrittenem bzw. metastasiertem Brustkrebs bekannt
businesswire.com
MRK